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Background
The cardiac hormone atrial natriuretic peptide (ANP)
exerts local, Guanylyl Cyclase-A (GC-A) – mediated myo-
cardial effects to antagonize the Ca2+
i-dependent hyper-
trophic growth response to Angiotensin II (Ang II). The
present study aimed to characterize the specific molecular
mechanisms mediating the reciprocal interactions
between the ANP/GC-A and the Ang II/AT1 systems in the
heart.
Results
Ca2+
i-transients and cell shortening were monitored in
Indo-1 loaded isolated, electrically paced adult murine
cardiomyocytes. Ang II (1–100 nM) acutely enhanced the
amplitude of Ca2+
i-transients, accelerated Ca2+
i-decay and
stimulated cell shortening. These effects were completely
prevented by ANP (100 nM). In contrast, the myocyte cal-
cium responses to β-adrenergic stimulation (10 nM iso-
prenaline) were not affected by ANP. To study the role of
cGMP-dependent protein kinase I (PKG I), we evaluated
the ANP effects on calcium regulation in myocytes from
transgenic mice with cardiac deletion of PKG I. The inhib-
itory effects of ANP on Ang II signaling were totally abol-
ished in PKG I-deficient myocytes. Rp-8-pCPT-cGMPs, a
membrane-permeable PKG inhibitor, mimicked the
effects of genetic PKG I deletion. One downstream target
of PKG I in the heart is regulator of G-protein signaling
(RGS)-2, which attenuates Ang II – Gαq protein signaling.
In RGS2 – deficient myocytes Ang II – induced Ca2+
i-
mobilization was enhanced. Moreover, the inhibitory
effect of ANP was totally abolished.
Conclusion
Taken together, our data indicate that PKG I is a down-
stream target activated by the ANP/GC-A/cGMP-signaling
pathway in cardiac myocytes. cGMP/PKG I-stimulated
phosphorylation of RGS2 and subsequent inhibition of
AT1/Gq-signaling appear to mediate the counterregula-
tion of the cardiac effects of Ang II by ANP.
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